Management tracks: Santhera, Acadia, Aeglea, Entrada, Kleo, Laboratory for Advanced Medicine, Imago, Glympse and Cognition

Santhera Pharmaceuticals Holding AG (SIX:SANN) said Dario Eklund will succeed Thomas Meier as CEO, effective Dec. 1. Meier will remain on the rare neuromuscular and pulmonary disease company's board